Blog

Clinical trials have always required informed consent, guaranteeing that participants are fully aware of the study’s goals, methods, and risks. However, conventional, lengthy consent forms often frustrate potential volunteers and delay enrollment, especially in vaccine clinical trials. A new study, funded by the NIH’s CTSA Program, points in a different direction.   This study implemented… Continue reading Clinical Trial Enrollment is Faster with eConsent

“In vaccine clinical trials, missing safety data in daily collection creates challenges in reporting safety outcomes to the agencies”. This was one of the key takeaways from our latest webinar on safety tracking in vaccine trials.   What is the result of poor tracking in vaccine clinical trials?   Missed cases or adverse events |… Continue reading Efficacy in Vaccine Clinical Trials. [Best Practices for Safety Tracking]  

In vaccine clinical trials, tracking participant safety is non-negotiable. Unlike drug trials, vaccine clinical trials involve healthy volunteers, making real-time monitoring of adverse events (AEs) crucial. However, many trials face challenges with delayed reporting, missed safety data, and compliance risks, potentially compromising trial outcomes. Why Is Safety Tracking So Challenging in Vaccine Clinical Trials? In… Continue reading Vaccine Clinical Trial Outcomes: The Impact of Monitoring Safety and Efficacy Tracking

Patient adherence and data accuracy are non-negotiable in vaccine clinical studies. Inadequate reporting can jeopardize regulatory submissions, raise expenses, and postpone the conclusion of studies.   However, many vaccine clinical trials are plagued by low adherence rates and ineffective data collection, which can result in insufficient safety monitoring and possible protocol violations.   TrialPal, a… Continue reading Protocol Adherence in Vaccine Clinical Trials with TrialPal